Early Versus Standard Initiation of Terlipressin for Acute Kidney Injury in ACLF: A Randomized Controlled Trial (eTerli Study)

ConclusionIn ACLF patients, early initiation of terlipressin for AKI persisting after 12  h of volume expansion with albumin helps in reduced short-term mortality and early AKI reversal with regression of ACLF stage. These results indicate need for change in current practice for terlipressin usage in HRS-AKI.
Source: Digestive Diseases and Sciences - Category: Gastroenterology Source Type: research